APG Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$398M Buy
932,138
+25,212
+3% +$13.7M 1.26% 11
2025
Q4
$447M Buy
906,926
+58,192
+7% +$32.9M 1.27% 10
2025
Q3
$350M Buy
848,734
+229,028
+37% +$107M 0.98% 13
2025
Q2
$214M Buy
619,706
+237,510
+62% +$99.3M 0.63% 30
2025
Q1
$176M Buy
382,196
+13,806
+4% +$7.48M 0.55% 37
2024
Q4
$185M Buy
368,390
+347,975
+1,705% +$191M 0.52% 37
2024
Q3
$11.3M Sell
20,415
-240,414
-92% -$142M 0.08% 179
2024
Q2
$135M Buy
260,829
+3,098
+1% +$1.77M 0.24% 96
2024
Q1
$139M Sell
257,731
-35,397
-12% -$19.9M 0.24% 96
2023
Q4
$141M Sell
293,128
-12,830
-4% -$6.21M 0.27% 88
2023
Q3
$155M Sell
305,958
-38,793
-11% -$20.7M 0.32% 72
2023
Q2
$165M Sell
344,751
-9,434
-3% -$5.09M 0.33% 71
2023
Q1
$188M Sell
354,185
-60,639
-15% -$34.2M 0.4% 64
2022
Q4
$228M Buy
414,824
+320,245
+339% +$170M 0.43% 59
2022
Q3
$49M Buy
94,579
+16,797
+22% +$9.4M 0.13% 189
2022
Q2
$40.4M Buy
77,782
+6,880
+10% +$3.79M 0.09% 241
2022
Q1
$37.6M Sell
70,902
-28,427
-29% -$16.3M 0.07% 272
2021
Q4
$58.3M Buy
99,329
+22,945
+30% +$14.3M 0.1% 223
2021
Q3
$37.7M Sell
76,384
-6,300
-8% -$3.46M 0.07% 294
2021
Q2
$35.2M Sell
82,684
-43,954
-35% -$20.7M 0.06% 325
2021
Q1
$49.2M Sell
126,638
-196,420
-61% -$93.8M 0.08% 273
2020
Q4
$123M Sell
323,058
-53,608
-14% -$25.1M 0.2% 126
2020
Q3
$142M Buy
376,666
+11,193
+3% +$4.62M 0.25% 106
2020
Q2
$118M Buy
365,473
+6,400
+2% +$2.15M 0.21% 117
2020
Q1
$102M Buy
359,073
+36,357
+11% +$11.5M 0.2% 126
2019
Q4
$93.4M Buy
322,716
+45,761
+17% +$13.9M 0.15% 177
2019
Q3
$74M Buy
276,955
+60,496
+28% +$17.3M 0.12% 205
2019
Q2
$55.8M Buy
216,459
+79,700
+58% +$22M 0.1% 245
2019
Q1
$33.3M Sell
136,759
-19,000
-12% -$4.73M 0.06% 310
2018
Q4
$30.5M Buy
155,759
+25,100
+19% +$5.89M 0.06% 295
2018
Q3
$27.5M Buy
130,659
+1,000
+0.8% +$230K 0.05% 333
2018
Q2
$23M Sell
129,659
-16,700
-11% -$3.54M 0.04% 340
2018
Q1
$24.6M Sell
146,359
-300
-0.2% -$63K 0.05% 320
2017
Q4
$23.2M Buy
146,659
+5,580
+4% +$1.07M 0.04% 345
2017
Q3
$26.7M Buy
141,079
+18,900
+15% +$3.42M 0.04% 360
2017
Q2
$21.3M Sell
122,179
-145,848
-54% -$24.5M 0.04% 401
2017
Q1
$41.2M Sell
268,027
-464,213
-63% -$71M 0.08% 318
2016
Q4
$98M Buy
732,240
+25,700
+4% +$3.79M 0.18% 160
2016
Q3
$112M Buy
706,540
+119,500
+20% +$18.4M 0.2% 153
2016
Q2
$86.7M Buy
587,040
+109,307
+23% +$16.1M 0.16% 181
2016
Q1
$67.6M Buy
477,733
+121,322
+34% +$16.3M 0.14% 205
2015
Q4
$50.6M Sell
356,411
-49,143
-12% -$6.55M 0.12% 225
2015
Q3
$49.6M Sell
405,554
-51,402
-11% -$6.7M 0.11% 222
2015
Q2
$59.3M Hold
456,956
0.12% 221
2015
Q1
$61.4M Buy
456,956
+8,178
+2% +$1.05M 0.13% 206
2014
Q4
$56.2M Buy
448,778
+48,938
+12% +$5.95M 0.11% 229
2014
Q3
$48.7M Buy
399,840
+31,332
+9% +$3.81M 0.1% 243
2014
Q2
$43.5M Buy
368,508
+116,809
+46% +$13.7M 0.09% 249
2014
Q1
$30.3M Buy
251,699
+3,360
+1% +$399K 0.08% 268
2013
Q4
$27.7M Sell
248,339
-129,561
-34% -$12.9M 0.08% 267
2013
Q3
$34.8M Sell
377,900
-62,597
-14% -$5.66M 0.11% 230
2013
Q2
$37.3M Buy
+440,497
New +$36.7M 0.12% 220

Other funds holding TMO

APG Asset Management's TMO Position: Q1 2026 in Review

APG Asset Management increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, buying an estimated $13.7M and bringing the position to 932,138 shares worth $398M. The position accounts for 1.26% of the portfolio, ranked #11.

APG Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $447M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • APG Asset Management held 932,138 shares of Thermo Fisher Scientific worth $398M as of Q1 2026.
  • APG Asset Management bought 25,212 Thermo Fisher Scientific shares in Q1 2026, an estimated $13.7M.
  • Thermo Fisher Scientific made up 1.26% of APG Asset Management's portfolio in Q1 2026, its #11 holding.
  • APG Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • APG Asset Management's Thermo Fisher Scientific position peaked at $447M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.